Blozo, Raymund A.

HRN: 27-32-46  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/06/2025
CLINDAMYCIN 150MG/ML, 4ML (AMP)
10/06/2025
10/13/2025
IVT
300mg
Q6
Cellulitis, Right Lower Extremity
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: